Use of Epoetin for Anemia in Chronic Renal Failure

File Name		Description			Software	Version		File	Size
__________________________________________________________________________________________________________
01front.doc		Microsoft Word® Document	MS Word®	97 SR-1		39KB	7 pages
Contents: Cover, Title Page, Preface, Structured Abstract

02conts.doc		Microsoft Word® Document	MS Word®	97 SR-1		24KB	2 pages
Contents: Table of Contents

03summ.doc		Microsoft Word® Document	MS Word®	97 SR-1		85KB	12 pages
Contents: Summary: Overview; Reporting the Evidence; Methodology; Findings; 
Priorities for Future Research

04chap1.doc		Microsoft Word® Document	MS Word®	97 SR-1		70KB	11 pages
Contents: Chapter 1. Introduction: Scope and Objectives; Key Questions; Background; 
Clinical Practice Guidelines for Anemia in Chronic Renal Failure; Epoetin; 
Table 1. FDA-approved uses of epoetin alfa and dosing recommendations

05chap2.doc		Microsoft Word® Document	MS Word®	97 SR-1		65KB	10 pages
Contents: Chapter 2. Methodology: Overview; Technical Advisors; Search Strategy 
for the Identification of Articles; Determining Study Eligibility; Stages of Study Selection; 
Table 2. Reasons for study exclusion; Data Abstraction; Evaluation of Study Quality


06chap3.doc		Microsoft Word® Document	MS Word®	97 SR-1		278KB	47 pages
Contents: Chapter 3. Results and Conclusions: Overview; Part I: Adult Patients with 
Chronic Renal Failure; Table 3. Overview of study quality and relevance: Results and conclusions, 
Part I; Table 4. Overview of outcomes reported in each study: Results and conclusions, Part I; 
Figure 1. Mean Mortality Rate as a Function of the Average Hematocrit Value; 
Table 5. Summary of results for Pickett, Theberge, Brown, et al., 1999; 
Part II: Pediatric Patients with Chronic Renal Failure; Table 6. Summary of observed effect 
on blood pressure in selected studies using epoetin to raise Hct over 30 percent in pediatric 
patients; Part III: Subpopulations of Interest (With or Without Chronic Renal Failure); 
Table 7. Overview of study quality: Results and conclusions, Part III; 
Table 8. Overview of outcomes reported in each study: Results and conclusions, Part III


07chap4.doc		Microsoft Word® Document	MS Word®	97 SR-1		33KB	2 pages
Contents: Chapter 4. Future Research

08refs.doc		Microsoft Word® Document	MS Word®	97 SR-1		38KB	4 pages
Contents: References

09etbls.doc		Microsoft Word® Document	MS Word®	97 SR-1		293KB	47 pages
Contents: Acronyms and Abbreviations Used in Evidence Tables; 
Evidence Table 1. Randomized controlled clinical studies; 
Evidence Table 2. Nonrandomized controlled clinical trials; 
Evidence Table 3. Studies reporting cross-sectional analyses; 
Evidence Table 4. Mortality; 
Evidence Table 5. Quality of life; 
Evidence Table 6. Hospital utilization; 
Evidence Table 7. Use of red blood cell transfusion; 
Evidence Table 8. Cardiac health outcomes; 
Evidence Table 9. Cardiac intermediate health outcomes; 
Evidence Table 10. Exercise performance intermediate health outcomes; 
Evidence Table 11. Cognitive function intermediate health outcomes; 
Evidence Table 12. Sleep pattern intermediate health outcomes; 
Evidence Table 13. Nutritional status intermediate outcomes; 
Evidence Table 14. Treatment-related morbidity associated with normalization of hematocrit; 
Evidence Table 15. Randomized controlled clinical studies; 
Evidence Table 16. Studies reporting cross-sectional analyses; 
Evidence Table 17. Studies addressing impact of cardiovascular disease on relationship 
between hematocrit and outcomes; 
Evidence Table 18. Studies addressing impact of cerebrovascular disease on relationship 
between hematocrit and outcomes

10biblio.doc		Microsoft Word® Document	MS Word®	97 SR-1		328KB	51 pages
Contents: Bibliography

11appa.doc		Microsoft Word® Document	MS Word®	97 SR-1		27KB	5 pages
Contents: Appendix A. Technical Advisory Group, External Reviewers, and Medical Advisory Panel

12appb.doc		Microsoft Word® Document	MS Word®	97 SR-1		24KB	2 pages
Contents: Appendix B. Data Abstraction Forms: Renal

13appc.doc		Microsoft Word® Document	MS Word®	97 SR-1		22KB	1 page
Contents: Appendix C. Acronyms and Abbreviations
__________________________________________________________________________________________________________

AHRQ Publication No. 01-E060
Current as of June 2001